NZX50 slides to nine-month low

NZX50 slides to nine-month low
A new drug has weighed on Fisher and Paykel's shares. (Image: Getty)
Graham Skellern
A weight-reducing drug is causing trouble for Fisher and Paykel Healthcare as the New Zealand sharemarket chalked up its sixth successive fall.The S&P/NZX 50 Index was on a downward slide all day and closed at 11,344.11, down 82.73 points or 0.72% – its lowest level for nine months.The index has now fallen 1.8% for the year and was at 11308.31 points on November 28.There were 42 gainers and 84 decliners on the main board, with 28.19 million shares worth $102.5m changing hands.Under pressureMarket heavyweight Fisher and Paykel Healthca...

More Markets

Eroad posts loss in half-year speedbump
Markets

Eroad posts loss in half-year speedbump

A soft NZ dollar and economic pressures had a notable impact, but the CEOs are optimistic.

Radius Care's run continues as earnings jump 14%
Markets

Radius Care's run continues as earnings jump 14%

The small-cap aged care services company's shares have lifted 57% this year. 

Channel looks to raise $50m, inks deal with Fletcher subsidiary
Markets

Channel looks to raise $50m, inks deal with Fletcher subsidiary

Projects expected to deliver $120m in incremental revenue over 15-year period. 

Margaret Warrington appointed Summerset's CFO
Markets

Margaret Warrington appointed Summerset's CFO

Warrington will join the group in late February next year.